Skip Navigation
Skip to contents




11 results

A Case of Erdheim-Chester Disease with Asymptomatic Renal Involvement

Lee HJ, Lee KY, Shin DY, Lee YG, Choi SY, Moon KC, Han IK, Kim TM

  • Cancer Res Treat.
  • 2012 Jun;44(2):146-150.
Erdheim-Chester disease is a rare non-Langerhans-cell histiocytosis involving bones and multiple organs. Its clinical course can vary, from an asymptomatic state to a fatal disease, with renal involvement being a...
Metastatic Skin Lesions on Lower Extremities in a Patient with Recurrent Serous Papillary Ovarian Carcinoma: A Case Report and Literature Review

Kim MK, Kim SH, Lee YY, Choi CH, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG

  • Cancer Res Treat.
  • 2012 Jun;44(2):142-145.
Clinical observation of skin metastasis in ovarian cancer cases is relatively uncommon. And distant metastatic skin lesions including the extremities are much rarer still as most metastatic skin lesions are...
Irradiation of Donor Mononuclear Cells for Treatment of Chemorefractory Metastatic Solid Cancers: A Community-Based Immune Transplant Pilot Study

Reynolds J, Watkins JM, Dufan TA, Kubsad SS

  • Cancer Res Treat.
  • 2012 Jun;44(2):133-141.
PURPOSE: Chemotherapy has demonstrated ability to generate tumor antigens secondary to induction of apoptosis, against which human leukocyte antigen-compatible, irradiated, related donor mononuclear cells may be administered with immune stimulation...
A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer

Choi JG, Seo JH, Oh SC, Choi CW, Kim JS

  • Cancer Res Treat.
  • 2012 Jun;44(2):127-132.
PURPOSE: The purpose of this study was to determine the efficacy and safety of treatment using gemcitabine and capecitabine for patients with advanced pancreatic cancer. MATERIALS AND METHODS: Patients with advanced...
Apolipoprotein E (APOE) Polymorphisms and Susceptibility to Breast Cancer: A Meta-Analysis

Saadat M

  • Cancer Res Treat.
  • 2012 Jun;44(2):121-126.
PURPOSE: Apolipoprotein E (APOE, MIM: 107741) has three functionally distinct isoforms of the protein (E2, E3, and E4), encoded by corresponding alleles epsilon2, epsilon3, and epsilon4, which have been well...
Trends in Cancer Screening Rates among Korean Men and Women: Results from the Korean National Cancer Screening Survey (KNCSS), 2004-2011

Park B, Choi KS, Lee YY, Jun JK, Seo HG

  • Cancer Res Treat.
  • 2012 Jun;44(2):113-120.
PURPOSE: The Korean National Cancer Screening Survey (KNCSS) is a nationwide survey conducted annually, since 2004. This study was conducted in order to report on trends in rates of cancer...
Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treatment Outcomes and Analysis of Prognostic Factors

Kong M, Hong SE, Choi WS, Kim SY, Choi J

  • Cancer Res Treat.
  • 2012 Jun;44(2):104-112.
PURPOSE: This study was designed to investigate the long-term oncologic outcomes for locally advanced rectal cancer patients after treatment with preoperative concurrent chemoradiotherapy followed by total mesorectal excision, and to...
Phase II Study of Consolidation Chemotherapy after Adjuvant or Primary Concurrent Chemoradiation Using Paclitaxel and Carboplatin to Treat High-Risk Early-Stage or Locally Advanced Cervical Cancer

Kim HS, Kim MK, Kim HJ, Han SS, Kim JW

  • Cancer Res Treat.
  • 2012 Jun;44(2):97-103.
PURPOSE: This study investigated the efficacy and toxicity associated with consolidation chemotherapy using paclitaxel and carboplatin after concurrent chemoradiation (CCR) in cervical cancer patients. MATERIALS AND METHODS: From a total of...
Clinical Practice Guideline for Accurate Diagnosis and Effective Treatment of Gastrointestinal Stromal Tumor in Korea

Kang YK, Kang HJ, Kim KM, Sohn T, Choi D, Ryu MH, Kim WH, Yang HK, Korean GIST Study Group (KGSG)

  • Cancer Res Treat.
  • 2012 Jun;44(2):85-96.
Despite their rarity in incidence and prevalence, gastrointestinal stromal tumors (GISTs) have emerged as a distinct and noteworthy pathogenetic entity. The clinical management of GISTs has rapidly evolved due to...
Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer

Kim DN, Nam TK, Choe KS, Choy H

  • Cancer Res Treat.
  • 2012 Jun;44(2):74-84.
Locally advanced non-small cell lung cancer (NSCLC) is a heterogeneous disease, and we have embarked on an era where patients will benefit from individualized therapeutic strategies based on identifiable molecular...
New Step of Joint Publication with the Korean Association for Clinical Oncology

Kim IH

  • Cancer Res Treat.
  • 2012 Jun;44(2):73-73.
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: